Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Muller

Showing results (261-270 of 271) with videos related to

Pageof 28
Sort By:
Photoacoustics|June 30, 2026
Hybrid three-dimensional full-view multi-wavelength photoacoustic and ultrasound breast tomographyM Dantuma, F Lucka, S C Kruitwagen, et al.
Plos Computational Biology|April 13, 2012
RNA-Seq mapping and detection of gene fusions with a suffix array algorithmOnur Sakarya, Heinz Breu, Milan Radovich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer GroupJ J M Kwakman, L H J Simkens, J M van Rooijen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2014
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trialA J Breugom, W van Gijn, E W Muller, et al.
ESC Heart Failure|June 27, 2026
Five-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation: Results From the Tendyne Expanded Clinical StudyDavid W Muller, Alison Duncan, Paul Sorajja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropeniaMaureen J Aarts, Frank P Peters, Caroline M Mandigers, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
Circulation. Genomic and Precision Medicine|October 30, 2020
Spontaneous Coronary Artery Dissection: Insights on Rare Genetic Variation From Genome SequencingKeren J Carss, Anna A Baranowska, Javier Armisen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropeniaMaureen J Aarts, Janneke P Grutters, Frank P Peters, et al.
JACC. Cardiovascular Interventions|September 7, 2024
Outcomes Following Transcatheter Mitral Valve Replacement Using Dedicated Devices in Patients With Mitral Annular CalcificationAugustin Coisne, Sebastian Ludwig, Andrea Scotti, et al.
Pageof 28

Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
Photoacoustics|June 30, 2026
Hybrid three-dimensional full-view multi-wavelength photoacoustic and ultrasound breast tomographyM Dantuma, F Lucka, S C Kruitwagen, et al.
Plos Computational Biology|April 13, 2012
RNA-Seq mapping and detection of gene fusions with a suffix array algorithmOnur Sakarya, Heinz Breu, Milan Radovich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2017
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer GroupJ J M Kwakman, L H J Simkens, J M van Rooijen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2014
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trialA J Breugom, W van Gijn, E W Muller, et al.
ESC Heart Failure|June 27, 2026
Five-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation: Results From the Tendyne Expanded Clinical StudyDavid W Muller, Alison Duncan, Paul Sorajja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropeniaMaureen J Aarts, Frank P Peters, Caroline M Mandigers, et al.
Circulation. Population Health and Outcomes|January 19, 2026
Estimating the Placebo Effect on Patient-Reported Outcomes in Sham-controlled Device Trials: Insights from REDUCE LAP-HF IIAndrew A Girard, Uma Mylavarapu, Jan Komtebedde, et al.
Circulation. Genomic and Precision Medicine|October 30, 2020
Spontaneous Coronary Artery Dissection: Insights on Rare Genetic Variation From Genome SequencingKeren J Carss, Anna A Baranowska, Javier Armisen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2013
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropeniaMaureen J Aarts, Janneke P Grutters, Frank P Peters, et al.
JACC. Cardiovascular Interventions|September 7, 2024
Outcomes Following Transcatheter Mitral Valve Replacement Using Dedicated Devices in Patients With Mitral Annular CalcificationAugustin Coisne, Sebastian Ludwig, Andrea Scotti, et al.
Pageof 28